科研成果详情

题名Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation
作者
发表日期2024
发表期刊JOURNAL OF INFLAMMATION RESEARCH   影响因子和分区
语种英语
原始文献类型Review
关键词endometrial cancer pyroptosis NLRP3 caspase-1 GSDMD IL-1(3 IL-18
其他关键词HYDROGEN-RICH WATER ; NONCANONICAL INFLAMMASOME ACTIVATION ; THIOREDOXIN-INTERACTING PROTEIN ; SPINAL-CORD-INJURY ; CELL-DEATH ; MOLECULAR-MECHANISMS ; GASDERMIN-D ; MACROPHAGE APOPTOSIS ; NLRP3 INFLAMMASOMES ; INDUCE PYROPTOSIS
摘要Pyroptosis is an inflammatory cell death induced by inflammasomes that release several pro-inflammatory mediators such as interleukin-18 (IL-18) and interleukin-1 beta (IL-1 beta). Pyroptosis, a type of programmed cell death, has recently received increased interest both as a therapeutic and immunological mechanism. Numerous studies have provided substantial evidence supporting the involvement of inflammasomes and pyroptosis in a variety of pathological conditions including cancers, nerve damage, inflammatory diseases and metabolic conditions. Researchers have demonstrated that dysregulation of pyroptosis and inflammasomes contribute to the progression of endometriosis and gynecological malignancies. Current research also indicates that inflammasome and pyroptosisdependent signaling pathways may further induce the progression of endometrial cancer (EC). More specifically, dysregulation of NLR family pyrin domain 3 (NLRP3) and caspase-1-dependent pyroptosis play a contributory role in the pathogenesis and development of EC. Therefore, pyroptosis-regulated protein gasdermin D (GSDMD) may be an independent prognostic biomarker for the detection of EC. This review presents the molecular mechanisms of pyroptosis-dependent signaling pathways and their contributory role and function in advancing EC. Moreover, this review offers new insights into potential future applications and innovative approaches in utilizing pyroptosis to develop effective anti-cancer therapies.
资助项目Key Research and Development Program of Zhejiang Province [2024C03171]; Key Research and Development Project of Lishui [2023zdyf15]; Public Welfare Technology Research Funding Project of Zhejiang [LTGY24H100002, LLSSY24H160003]; Zhejiang Provincial Medical and Health Science and Technology Project [2022RC302]; Post-Doctoral Research Start-Up Fund of Lishui People's Hospital, Lishui, Zhejiang, China [2023bsh001]
出版者DOVE MEDICAL PRESS LTD
ISSN1178-7031
EISSN1178-7031
卷号17页码:7037-7056
DOI10.2147/JIR.S486878
页数20
WOS类目Immunology
WOS研究方向Immunology
WOS记录号WOS:001330271400001
收录类别SCIE ; PUBMED
URL查看原文
PubMed ID39377044
通讯作者地址[Wang, Shuanghu;Shao, Chuxiao]Wenzhou Med Univ, Affiliated Hosp 1, Lishui Peoples Hosp, Lishui Hosp,Key Lab Joint Diag & Treatment Chron L, Lishui 323000, Zhejiang, Peoples R China.
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/220795
专题附属第一医院
其他_附属第六医院(丽水市人民医院)
通讯作者Wang, Shuanghu; Shao, Chuxiao
作者单位
1.Wenzhou Med Univ, Affiliated Hosp 1, Lishui Peoples Hosp, Lishui Hosp,Key Lab Joint Diag & Treatment Chron L, Lishui 323000, Zhejiang, Peoples R China;
2.Wenzhou Med Univ, Mol Pharmacol Res Ctr, Sch Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China
第一作者单位附属第一医院;  附属第六医院(丽水市人民医院);  温州医科大学
通讯作者单位附属第一医院;  附属第六医院(丽水市人民医院)
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Al Mamun, Abdullah,Geng, Peiwu,Wang, Shuanghu,et al. Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation[J]. JOURNAL OF INFLAMMATION RESEARCH,2024,17:7037-7056.
APA Al Mamun, Abdullah, Geng, Peiwu, Wang, Shuanghu, & Shao, Chuxiao. (2024). Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation. JOURNAL OF INFLAMMATION RESEARCH, 17, 7037-7056.
MLA Al Mamun, Abdullah,et al."Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation".JOURNAL OF INFLAMMATION RESEARCH 17(2024):7037-7056.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Al Mamun, Abdullah]的文章
[Geng, Peiwu]的文章
[Wang, Shuanghu]的文章
百度学术
百度学术中相似的文章
[Al Mamun, Abdullah]的文章
[Geng, Peiwu]的文章
[Wang, Shuanghu]的文章
必应学术
必应学术中相似的文章
[Al Mamun, Abdullah]的文章
[Geng, Peiwu]的文章
[Wang, Shuanghu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。